Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL
Soergel David sold 844 Madrigal Pharmaceuticals, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 18, 2026
On May 18, 2026, Soergel David (Chief Medical Officer) sold 844 Madrigal Pharmaceuticals, Inc. shares at US$515.90 for US$435K, leaving 11,075 shares. Filed May 18, 2026 (Form 4).
- Sold
- 844 shares
- Price
- US$515.90
- Value
- US$435K
- Holding after
- 11,075 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Sale | 844 | US$515.90 | 11,075 | Direct |
Source
Related
- Madrigal Pharmaceuticals, Inc.
- Soergel David
- Madrigal Pharmaceuticals, Inc. shareholders
- Form 4 · Soergel David · Jun 1, 2026
- Form 4 · Sibold William John · Sep 11, 2026
- Form 4 · Kelley Shannon T · Aug 20, 2026
- Form 4 · Reed John C · Aug 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Sibold William John · Jul 20, 2026